1) Compare tactic performance for Cardiology vs Oncology in 2025Q2 and recommend where to shift 20% of Cardiology spend.
2) For Endocrinology in 2025Q1â€“Q2, which two tactics have the highest ROI stability? Suggest next best action.
3) If we need quick wins next quarter, should we emphasize Webinars or Email for Oncology? Provide rationale using retrieved KB.
